|
|
|
|
|
|
| Industry update |
| //The Romaco Group appointed Dirk Bauernfeind as Managing Director of Romaco Pharmatechnik GmbH (Karlsruhe, Germany). He will share the responsibility for the company with Carsten Strenger, CFO/COO of the Romaco Group. As of July 2016, Paulo Alexandre will concentrate on his core function as CEO of the Romaco Group.//Umecrine Cognition AB (Stockholm, Sweden) announced that Dr. Bruce Scharschmidt has been appointed as a new member of its board of directors and Senior Development Adviser.//Sequana Medical AG (Zurich, Switzerland) appointed Rolf A. Classon, former top executive of Bayer AG and Pharmacia AB, as Chairman of the Board of Directors.//Envigo (Huntingdon, UK) announced that its Board of Directors appointed Dr. Adrian Hardy as President and Chief Executive Officer, and that he will join the Company's Board of Directors. Dr. Hardy joined Envigo in 2002.// |
|
|
| |
|
|
